Sulfurcell Receives New Orders for Thin-Film Solar Panels in Asian Market

Sulfurcell GmbH, one of the leading manufacturers of CIS thin-film solar modules, has concluded supply agreements with new customers in India and China in excess of 16 megawatts (MW).

In China, over 10 MW of Sulfurcell’s solar panels will be deployed in new construction and building integrated applications. In India, over 6 MW of the company’s modules will be used for commercial rooftop projects.

“Sulfurcell’s innovative solar energy solutions have been met with great interest in the Asian market,” says CEO and company founder Dr. Nikolaus Meyer. “The new supply agreements in China and Asia for over 16MW of our CIS modules mark an important stage for us as we expand into the global market.”

Sulfurcell has concluded a supply agreement exceeding 10 MW with a Chinese company that plans to deploy Sulfurcell solar panels for large-scale construction projects and building integration (BIPV) applications in mainland China. Sulfurcell’s high quality black modules are especially well suited for building-integrated solar energy systems.

In India, Sulfurcell will provide over 6 MW of modules by 2012 to the Prime Group of New Delhi for mainly commercial rooftop projects. The Prime Group, which has subsidiaries in Europe and the Far East, produces and operates high-tech products and is also active in the renewable energy sector.

“We value not just the technological competitive edge offered by the Sulfurcell modules, which are particularly good at generating high yields in spite of the heat of this region, but also Sulfurcell’s reputation for high quality,” said Surinder Mehta, Founder of the Prime Group. “Our agreement with Sulfurcell marks the beginning of a what we hope will be a mutually beneficial collaboration.”

“Sulfurcell’s high quality and powerful thin-film solar modules are uniquely well-suited for BIPV,” said Dr. Nikolaus Meyer. “In the coming years, we hope to help shape the building-integrated photovoltaics segment with expertise and innovations.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.